Members |
targetComponentId |
Ara nobilis |
Diopsittaca nobilis (organism) |
Ara noblis cumanensis |
Diopsittaca nobilis subspecies cumanensis (organism) |
Arachnia propionica |
Pseudopropionibacterium propionicum (organism) |
Aratinga guarouba |
Guaruba guarouba (organism) |
Arcanobacterium bernardiae |
Trueperella bernardiae (organism) |
argatroban 100 mg/ml, injektionsvätska, lösning, flaska 2,5 ml |
Product containing precisely argatroban 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Arhinencephaly |
Holoprosencephaly sequence |
aripiprazol 7,5 mg/ml, injektionsvätska, lösning, flaska |
Aripiprazole 7.5 mg/mL solution for injection |
Arizona infection |
Salmonella enterica subspecies arizonae infection (disorder) |
operation av arm |
Surgical repair of upper extremity |
Arteriography of unlisted intra-abdominal arteries |
Angiography of artery |
Arteriography of unlisted site |
Angiography of artery |
arteriopatisk impotens |
Erectile dysfunction due to arterial disease (disorder) |
klinisk handläggningsplan för artrit |
Arthritis clinical management plan (record artifact) |
Arthroascus schoenii |
Saccharomycopsis schoenii (organism) |
Arthrobacter duodecadis |
Tetrasphaera duodecadis (organism) |
Arthrobacter flavescens |
Microbacterium flavescens (organism) |
Arthrobacter siderocapsulatus |
Pseudomonas putida |
Arthrobacter terregens |
Microbacterium terregens (organism) |
Arthrobacter tumescens |
Terrabacter tumescens |
Arthroderma cajetani |
Paraphyton cookei |
Arthropathy associated with a condition classifiable elsewhere |
Arthropathy associated with another disorder |
Arthropathy associated with a mycosis, NEC |
Arthropathy associated with a mycosis |
Arthropathy associated with bacterial disease, NEC |
Arthropathy associated with bacterial disease |
Arthropathy associated with helminthiasis, NEC |
Arthropathy associated with helminthiasis |
Arthropathy associated with viral disease, NEC |
Arthropathy associated with viral disease |
Arthroplasty - action |
Reconstruction - action |
Arthrotomy of hip |
Hip joint incision |
Arthrotomy of knee for infection |
Arthrotomy of knee |
Arthrotomy of knee for infection with drainage |
Arthrotomy of knee with drainage |
Arthrotomy of knee for infection with exploration |
Arthrotomy of knee with joint exploration |
Arthrotomy of knee for infection with removal of foreign body |
Arthrotomy of knee |
artikainhydroklorid 40 mg + adrenalin 10 mikrogram, injektionsvätska, lösning, flaska |
Product containing only articaine and epinephrine in parenteral dose form (medicinal product form) |
artikainhydroklorid 40 mg/ml + adrenalin (1:200 000), injektionslösning |
Product containing only articaine and epinephrine in parenteral dose form (medicinal product form) |
Articular cartilage disorder of other site |
Articular cartilage disorder |
Artificial insemination with sperm washing and capacitation |
Artificial insemination with sperm washing and capacitation |
askorbinsyra 250 mg, tuggtablett med apelsinsmak |
Product containing precisely ascorbic acid 250 milligram/1 each conventional release chewable tablet (clinical drug) |
Aseptic necrosis of other specified site, NEC |
Aseptic necrosis |
biverkning av aserbin |
Adverse reaction to benzoic acid and/or malic acid and/or salicylic acid ester (disorder) |
Aspartic proteinase |
Aspartic proteinase |
Aspergillus amstelodami |
Aspergillus montevidensis (organism) |
Aspergillus hollandicus |
Aspergillus montevidensis (organism) |
Aspiration of joint |
Arthrocentesis |
Aspiration of unspecified fluid |
Pulmonary aspiration of fluid |
acetylsalicylsyra 400 mg + kodein 8 mg, dispergerbar tablett |
Aspirin and codeine only product in oral dose form |
acetylsalicylsyra 500 mg + kodein 8 mg, dispergerbar tablett |
Aspirin and codeine only product in oral dose form |
acetylsalicylsyra 227,5 mg, tuggummitablett |
Aspirin only product in oral dose form |
acetylsalicylsyra 227,5 mg, medicinskt depåtuggummi |
Aspirin only product in oral dose form |
acetylsalicylsyra 300 mg, dispergerbar tablett |
Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
acetylsalicylsyra 300 mg, löslig tablett |
Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
acetylsalicylsyra 500 mg, löslig tablett |
Aspirin 2.5 mg/mL oral solution |
acetylsalicylsyra 800 mg, enterotablett |
Aspirin only product in oral dose form |
acetylsalicylsyra 800 mg, tablett med modifierad frisättning |
Aspirin only product in oral dose form |
extrakt av acetylsalicylsyra |
Product containing aspirin (medicinal product) |
acetylsalicylsyra 500 mg + papaveretum 7,71 mg, dispergerbar tablett |
Aspirin and papaveretum only product |
bedömning enligt CADL-2 (communication abilities of daily living, second edition) |
Assessment using Communication Activities of Daily Living Second Edition (procedure) |
bedömning enligt WHO:s verktyg för skattning av frakturrisk, FRAX |
Hip fracture probability assessment using FRAX (fracture risk assessment tool) |
bedömning enligt WHO:s verktyg för skattning av osteoporotisk frakturrisk, FRAX |
Osteoporotic fracture probability assessment using osteoporotic fracture risk assessment tool (procedure) |
tillfällig försämring och akutbehandling av astma sedan förra besöket |
Emergency asthma patient visit since last encounter (situation) |
Asthma causes daytime symptoms 1 to 2 times per month |
Asthma causes daytime symptoms 1 to 2 times per month (finding) |
Asthma causes daytime symptoms 1 to 2 times per week |
Asthma causes daytime symptoms 1 to 2 times per week (finding) |
Asthma causes daytime symptoms most days |
Asthma causes daytime symptoms most days (finding) |
Asthma causes night symptoms 1 to 2 times per month |
Asthma causes night symptoms 1 to 2 times per month (finding) |
klinisk handläggningsplan för astma |
Asthma clinical management plan |
Asthma limits walking on the flat |
Asthma limits walking on the flat (finding) |
astma med status asthmaticus |
Acute severe exacerbation of asthma (disorder) |
astrocytom |
Astrocytoma |
Astrovirus |
Family Astroviridae (organism) |
ataxi samtidig med och orsakad av cerebrotendinös xantomatos |
Ataxia due to cerebrotendinous xanthomatosis |
Atherosclerosis of other specified arteries |
Atherosclerosis |
Atorvastatin calcium 10mg tablet |
Atorvastatin (as atorvastatin calcium) 10 mg oral tablet |
Atorvastatin calcium 20mg tablet |
Atorvastatin (as atorvastatin calcium) 20 mg oral tablet |
Atorvastatin calcium 40mg tablet |
Atorvastatin (as atorvastatin calcium) 40 mg oral tablet |
atosiban 7,5 mg/ml, infusionskoncentrat, flaska 5 ml |
Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Atovaquone+proguanil hydrochloride |
Product containing atovaquone and proguanil (medicinal product) |
atrakuriumbesylat 100 mg/ 10 ml, lösning |
Atracurium besilate 10 mg/mL solution for injection |
förmaksmyxom med lentiginos |
Carney complex (disorder) |
Atrophic age-related macular degeneration |
Nonexudative age-related macular degeneration (disorder) |
Atrophic glossitis |
Atrophy of tongue papillae |
atropin 2,1 mg + pralidoxim 600 mg, lösning, en autoinjektor |
Product containing only atropine and pralidoxime in parenteral dose form (medicinal product form) |
Atropine sulfate + edrophonium chloride 0.14mg/10mg injection |
Product containing only atropine and edrophonium (medicinal product) |
atropinsulfat 0,031 %, ögondroppar |
Product containing precisely atropine sulfate 310 microgram/1 milliliter conventional release eye solution (clinical drug) |
atropinsulfat 0,062 %, ögondroppar |
Atropine sulfate 620 microgram/mL eye solution |
atropinsulfat 0,1 %, ögondroppar |
Atropine sulfate 1 mg/mL eye solution |
atropinsulfat 0,25 %, ögondroppar |
Product containing precisely atropine sulfate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
atropinsulfat 140 mikrogram + edrofoniumklorid 10 mg, injektionsvätska, lösning, flaska |
Product containing only atropine and edrophonium (medicinal product) |
atropinsulfat 500 mikrogram/5 ml, oral lösning |
Atropine only product in oral dose form |
atropinsulfat 500 mikrogram/5 ml, sockerfri lösning |
Atropine only product in oral dose form |
atypisk absensepilepsi |
Atypical absence seizure |
atypiskt antipsykotiskt medel |
Anti-psychotic agent (substance) |
Auditory function |
Hearing |
Aurantimonas altamirensis |
Aureimonas altamirensis (organism) |
Aureobacterium |
Microbacterium |
Aureobacterium saperdae |
Microbacterium saperdae (organism) |
Aureobacterium species |
Microbacterium |
syndrom med aurikulookulär anomali och läppspalt |
Auricular abnormality, cleft lip, ocular abnormality syndrome |
autogen transplantation av vaskulariserad benvävnad |
Autogenous vascularised bone |
Autograft |
Autograft |
Autoimplant |
Autoimplant |
autointoxikation |
Intestinal dysbiosis |
Automobile mechanic |
Motor vehicle mechanic |